Bone Biologics Corporation
BBLG
$1.75
-$0.01-0.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.05M | 6.64M | 2.75M | 3.33M | 3.57M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 81.40K | 152.80K | 206.50K | 278.20K | 113.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 220.30K | 209.00K | 209.00K | 258.10K | 385.70K |
| Total Current Assets | 6.35M | 7.00M | 3.16M | 3.86M | 4.07M |
|
|
|||||
| Total Current Assets | 6.35M | 7.00M | 3.16M | 3.86M | 4.07M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 6.35M | 7.00M | 3.16M | 3.86M | 4.07M |
|
|
|||||
| Total Accounts Payable | 333.10K | 403.70K | 247.80K | 373.00K | 190.10K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.20K | 2.40K | 3.30K | 4.70K | 83.30K |
| Total Other Current Liabilities | 1.20K | 2.40K | 3.30K | 4.70K | 83.30K |
| Total Current Liabilities | 334.30K | 406.10K | 251.20K | 377.70K | 273.40K |
|
|
|||||
| Total Current Liabilities | 334.30K | 406.10K | 251.20K | 377.70K | 273.40K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 334.30K | 406.10K | 251.20K | 377.70K | 273.40K |
|
|
|||||
| Common Stock & APIC | 93.46M | 93.38M | 88.95M | 88.51M | 87.29M |
| Retained Earnings | -87.45M | -86.78M | -86.04M | -85.02M | -83.50M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 6.02M | 6.60M | 2.91M | 3.48M | 3.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.02M | 6.60M | 2.91M | 3.48M | 3.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.02M | 6.60M | 2.91M | 3.48M | 3.79M |
|
|
|||||